Devaprasath A, Chacko G
Neuropathology, Department of Neurological Sciences, Christian Medical College and Hospital Vellore - 632004, India.
Neurol India. 2003 Sep;51(3):336-40.
About 10% of meningiomas behave aggressively and are graded atypical or malignant with important therapeutic and prognostic implications. Routine histological parameters are inconsistent in the assessment of their aggressive behavior.
The aim of this study was to find a threshold level of the MIB-1 labeling index (MIB-1 LI) with the highest diagnostic validity in predicting histological atypia in a meningioma.
This was a retrospective study of all atypical and malignant meningiomas diagnosed at our center between January 1995 and June 2000 and which were identified from the General Pathology Registry.
These meningiomas were assessed histologically with respect to the individual criteria of atypia. They were categorized according to the WHO 2000 classification as benign, atypical and anaplastic meningiomas, WHO Grades I, II and III respectively and by immunohistochemical analysis using the MIB-1 monoclonal antibody.
The diagnostically useful cut-off level for the prediction of atypia was estimated by calculating the sensitivity and specificity of the MIB-1 LI at various levels and a receiver operated characteristic (ROC) analysis was performed. The correlation between the individual histological parameters was studied and the MIB-1 LI was obtained using Fisher's exact test.
Of the 40 meningiomas studied 21 were benign, 16 atypical and 3 anaplastic. Atypical tumors had a higher MIB-1 LI than benign tumors, with diagnostic validity highest at a threshold of 7%, with a sensitivity of 0.86 and a specificity of 0.93, giving a likelihood ratio of 17. The MIB-1 LI correlated well with mitotic activity and the other individual criteria in the WHO 2000 definition of atypia in a meningioma. MIB-1 LI did not, however, correlate well with brain invasion.
The MIB-1 LI has the highest validity in the diagnosis of atypia in meningiomas at a threshold level of 7%. The MIB-1 LI used in conjunction with histological features can help in making a recommendation regarding potentially aggressive behavior in meningiomas.
约10%的脑膜瘤具有侵袭性,被归类为非典型或恶性,这对治疗和预后具有重要意义。常规组织学参数在评估其侵袭性行为时并不一致。
本研究的目的是找到MIB-1标记指数(MIB-1 LI)的一个阈值水平,该阈值在预测脑膜瘤组织学非典型性方面具有最高的诊断有效性。
这是一项对1995年1月至2000年6月在本中心诊断的所有非典型和恶性脑膜瘤进行的回顾性研究,这些病例来自一般病理学登记处。
根据非典型性的各个标准对这些脑膜瘤进行组织学评估。根据世界卫生组织2000年分类,它们分别被归类为良性、非典型和间变性脑膜瘤,即世界卫生组织I级、II级和III级,并使用MIB-1单克隆抗体进行免疫组织化学分析。
通过计算不同水平下MIB-1 LI的敏感性和特异性来估计预测非典型性的诊断有用截断水平,并进行受试者操作特征(ROC)分析。研究了各个组织学参数之间的相关性,并使用Fisher精确检验获得MIB-1 LI。
在研究的40例脑膜瘤中,21例为良性,16例为非典型,3例为间变性。非典型肿瘤的MIB-1 LI高于良性肿瘤,在阈值为7%时诊断有效性最高,敏感性为0.86,特异性为0.93,似然比为17。MIB-1 LI与有丝分裂活性以及世界卫生组织2000年脑膜瘤非典型性定义中的其他个体标准相关性良好。然而,MIB-1 LI与脑侵袭的相关性不佳。
MIB-1 LI在诊断脑膜瘤非典型性方面,阈值水平为7%时具有最高的有效性。MIB-1 LI与组织学特征结合使用有助于对脑膜瘤潜在的侵袭性行为提出建议。